Table 1.
BL1a (μg/ml) | OKT1 (μg/ml) | UCHT2 (μg/ml) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Stimulus | 0 | 0·5 | 5 | 50 | 0·5 | 5 | 50 | 0·5 | 5 | 50 |
Experiment 1 | ||||||||||
Control | 995 ± 401 | 2250 ± 600 | 2188 ± 648 | 2734 ± 1106 | 1448 ± 230 | 1449 ± 465 | 1540 ± 548 | 1606 ± 877 | 2138 ± 218 | 1912 ± 523 |
sIgM | 3021 ± 334 | 5005 ± 1154 | 5751 ± 1504 | 8495 ± 1824 | 5563 ± 1298 | 4068 ± 1265 | 4306 ± 1906 | 2843 ± 693 | 5690 ± 1862 | 4647 ± 1517 |
CD40 | 18 325 ± 6428 | 20 204 ± 2974 | 19 880 ± 6592 | 20 841 ± 2727 | 18 502 ± 3771 | 18 133 ± 4833 | 14 689 ± 5474 | 30 099 ± 4016 | 26 428 ± 4423 | 17 529 ± 6674 |
sIgM + CD40 | 40 504 ± 4364 | 38 464 ± 4772 | 36 575 ± 4836 | 40 931 ± 4569 | 42 701 ± 4367 | 36 709 ± 4715 | 26796 ± 3890 | 49 168 ± 5760 | 32 125 ± 5341 | 22 905 ± 4122 |
Experiment 2 | ||||||||||
Control | 1474 ± 933 | 2027 ± 604 | 2047 ± 361 | 2634 ± 674 | 2031 ± 464 | 1834 ± 101 | 1459 ± 598 | 1721 ± 733 | 1884 ± 800 | 2127 ± 807 |
sIgM | 8354 ± 2526 | 6374 ± 1827 | 7058 ± 1258 | 7185 ± 1096 | 7629 ± 1385 | 4995 ± 2853 | 2555 ± 915 | 3372 ± 1318 | 5641 ± 2198 | 5163 ± 1495 |
CD40 | 23 291 ± 5754 | 17 383 ± 1573 | 18 462 ± 2437 | 22 029 ± 4992 | 23 533 ± 3467 | 225 851 ± 5231 | 21 252 ± 3784 | 28 242 ± 5763 | 22 009 ± 4461 | 20 633 ± 5898 |
sIgM + CD40 | 40 921 ± 6836 | 45 891 ± 8802 | 43 891 ± 3656 | 49 934 ± 8253 | 39 469 ± 6212 | 46 012 ± 5242 | 28 001 ± 3558 | 38 852 ± 8529 | 37 125 ± 3242 | 32 997 ± 3247 |
B cells (105 cells/well) were cultured for 3 days with: non-transfected mouse L cells (‘Control’); CD32-transfected mouse L cells and anti-IgM antibody at 0·5 µg/ml (‘sIgM’); CD40 ligand (CD40L)/CD32-transfected cells (‘CD40’); and CD40L/CD32-transfected L cells and anti-IgM antibody (‘sIgM + CD40’) in the presence or absence of CD5 mAbs. [3H]Thymidine ([3H]Tdr) incorporation was measured during the final 18 hr of culture. Values for [3H]Tdr uptake by mouse L cells alone were always less than 1000 counts per minute (c.p.m.) (results not shown).